Literature DB >> 2805215

Dengue haemorrhagic fever/dengue shock syndrome: lessons from the Cuban epidemic, 1981.

G P Kouri, M G Guzmán, J R Bravo, C Triana.   

Abstract

Dengue haemorrhagic fever/dengue shock syndrome (DHF/DSS) is one of the principal causes of hospitalization and death among children in several south-east Asian countries. Also, in the Region of the Americas, there has been an increase in the frequency of dengue fever epidemics and in the number of cases of DHF/DSS. In 1981 an epidemic of dengue haemorrhagic fever occurred in Cuba and this suggests that there is a high risk that such epidemics could recur in the region. The article summarizes the main clinical, virological, and epidemiological data obtained during the outbreak, some of which are reported for the first time.

Entities:  

Mesh:

Year:  1989        PMID: 2805215      PMCID: PMC2491263     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  8 in total

1.  Clinical and serologic study of Cuban children with dengue hemorrhagic fever/dengue shock syndrome (DHF/DSS).

Authors:  M G Guzmán; G Kourí; E Martínez; J Bravo; R Riverón; M Soler; S Vázquez; L Morier
Journal:  Bull Pan Am Health Organ       Date:  1987

2.  Why dengue haemorrhagic fever in Cuba? 2. An integral analysis.

Authors:  G P Kouri; M G Guzmán; J R Bravo
Journal:  Trans R Soc Trop Med Hyg       Date:  1987       Impact factor: 2.184

3.  Hemorrhagic dengue in Cuba: history of an epidemic.

Authors:  G Kourí; M G Guzmán; J Bravo
Journal:  Bull Pan Am Health Organ       Date:  1986

4.  Dengue hemorrhagic fever in Cuba, 1981: rapid diagnosis of the etiologic agent.

Authors:  G Kourí; P Más; M G Guzmán; M Soler; A Goyenechea; L Morier
Journal:  Bull Pan Am Health Organ       Date:  1983

5.  Epidemic dengue fever in Puerto Rico, 1977: a cost analysis.

Authors:  S D Von Allmen; R H López-Correa; J P Woodall; D M Morens; J Chiriboga; A Casta-Velez
Journal:  Am J Trop Med Hyg       Date:  1979-11       Impact factor: 2.345

Review 6.  Selective primary health care: strategies for control of disease in the developing world. XI. Dengue.

Authors:  S B Halstead
Journal:  Rev Infect Dis       Date:  1984 Mar-Apr

7.  Clinical observations on virologically confirmed fatal dengue infections in Jakarta, Indonesia.

Authors:  H Wulur; E Jahja; D J Gubler; W Suharyono; K Sorensen
Journal:  Bull World Health Organ       Date:  1983       Impact factor: 9.408

8.  Why dengue haemorrhagic fever in Cuba? 1. Individual risk factors for dengue haemorrhagic fever/dengue shock syndrome (DHF/DSS).

Authors:  J R Bravo; M G Guzmán; G P Kouri
Journal:  Trans R Soc Trop Med Hyg       Date:  1987       Impact factor: 2.184

  8 in total
  70 in total

1.  Aedes aegypti vectorial capacity is determined by the infecting genotype of dengue virus.

Authors:  Justin R Anderson; Rebeca Rico-Hesse
Journal:  Am J Trop Med Hyg       Date:  2006-11       Impact factor: 2.345

Review 2.  Emergence of the severe syndrome and mortality associated with dengue and dengue-like illness: historical records (1890 to 1950) and their compatibility with current hypotheses on the shift of disease manifestation.

Authors:  Goro Kuno
Journal:  Clin Microbiol Rev       Date:  2009-04       Impact factor: 26.132

3.  Dengue: where are we today?

Authors:  Maria Guadalupe Guzman; Susana Vázquez; Gustavo Kouri
Journal:  Malays J Med Sci       Date:  2009-07

4.  The epidemiology of dengue in the americas over the last three decades: a worrisome reality.

Authors:  José Luis San Martín; Olivia Brathwaite; Betzana Zambrano; José Orlando Solórzano; Alain Bouckenooghe; Gustavo H Dayan; María G Guzmán
Journal:  Am J Trop Med Hyg       Date:  2010-01       Impact factor: 2.345

Review 5.  Advances in dengue diagnosis.

Authors:  M G Guzmán; G Kourí
Journal:  Clin Diagn Lab Immunol       Date:  1996-11

Review 6.  The global distribution of yellow fever and dengue.

Authors:  D J Rogers; A J Wilson; S I Hay; A J Graham
Journal:  Adv Parasitol       Date:  2006       Impact factor: 3.870

7.  A highly conserved region between amino acids 221 and 266 of dengue virus non-structural protein 1 is a major epitope region in infected patients.

Authors:  Magot Diata Omokoko; Sabar Pambudi; Supranee Phanthanawiboon; Promsin Masrinoul; Chayanee Setthapramote; Tadahiro Sasaki; Motoki Kuhara; Pongrama Ramasoota; Akifumi Yamashita; Itaru Hirai; Kazuyoshi Ikuta; Takeshi Kurosu
Journal:  Am J Trop Med Hyg       Date:  2014-04-28       Impact factor: 2.345

8.  A single dose of any of four different live attenuated tetravalent dengue vaccines is safe and immunogenic in flavivirus-naive adults: a randomized, double-blind clinical trial.

Authors:  Anna P Durbin; Beth D Kirkpatrick; Kristen K Pierce; Daniel Elwood; Catherine J Larsson; Janet C Lindow; Cecilia Tibery; Beulah P Sabundayo; Donna Shaffer; Kawsar R Talaat; Noreen A Hynes; Kimberli Wanionek; Marya P Carmolli; Catherine J Luke; Brian R Murphy; Kanta Subbarao; Stephen S Whitehead
Journal:  J Infect Dis       Date:  2013-01-17       Impact factor: 5.226

9.  Bioinformatics in new generation flavivirus vaccines.

Authors:  Penelope Koraka; Byron E E Martina; Albert D M E Osterhaus
Journal:  J Biomed Biotechnol       Date:  2010-05-10

10.  The history of dengue outbreaks in the Americas.

Authors:  Olivia Brathwaite Dick; José L San Martín; Romeo H Montoya; Jorge del Diego; Betzana Zambrano; Gustavo H Dayan
Journal:  Am J Trop Med Hyg       Date:  2012-10       Impact factor: 2.345

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.